DarioHealth Corp. (DRIO) is a Healthcare stock trading at $7.47 (as of 2026-08-20), with a market capitalization of $73.40M and a trailing P/E of 0.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
DarioHealth Corp. is a digital therapeutics company offering technology-enabled programs and associated devices for health management across multiple conditions. Its offerings include metabolic, musculoskeletal, behavioral health, and chronic condition solutions, plus a care management platform and test-related consumables and monitoring devices for users in the U.S., Canada, the EU, Australia, and New Zealand.
DarioHealth Corp. delivers digital therapeutics for metabolic, musculoskeletal, behavioral health, and chronic condition management, and it also provides a care management platform plus device-specific disposable test strip cartridges and lancets, selling these solutions to customers through business-to-business and other healthcare channels.
The profit engine is recurring revenue tied to contracted annual recurring contracts and customer retention, supported by its proprietary care management platform (DarioEngage) and the availability of device-specific disposables (test strip cartridges and lancets).
| B2B | $0.0B |
| DTC | $0.0B |
Business quality (Weak): Mixed: solid gross margin, but the latest-quarter operating margin is deeply negative, and reported revenue is effectively 0.0B, so cost discipline and converting pipeline into contracted recurring revenue are central to the story.
Valuation: At 1× earnings, DRIO trades 98% below the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $7.47 |
| Market Cap | $73.40M |
| P/E Ratio | 0.6 |
| EV / EBITDA | -3.3 |
| Price / Book | 1.33 |
| Price / Sales | 3.50 |
| FCF Yield | -34.7% |
| Revenue (TTM) | $22.36M |
| Net Margin | -186.6% |
| Return on Equity | -64.8% |
| Debt / Equity | 0.66 |
| Current Ratio | 2.31 |
| Revenue Growth (YoY) | -3.6% |
| EPS Growth (YoY) | 372.2% |
| FCF Growth (YoY) | 0.8% |
| Altman Z-Score | -5.59 (distress) |
| Piotroski F-Score | 4/9 (moderate) |
| Stock P/E | 0.6 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | -97.0% |
| vs Industry | -98.0% |
| Top Institutional Holder | Nantahala Capital Management, LLC ($4.90M) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Erez Raphael |
| Employees | 196 |
| Country | US |
| IPO Date | 2016-03-14 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.